Sanli, Y. Et Al. 2010. Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?. JOURNAL OF NUCLEAR MEDICINE , vol.51 .

Sanli, Y., Turkmen, C., Mudun, A., Adalet, I., Unal, S., Bakir, B., ... Topuz, S.(2010). Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?. JOURNAL OF NUCLEAR MEDICINE , vol.51.

Sanli, Yasemin Et Al. "Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?," JOURNAL OF NUCLEAR MEDICINE , vol.51, 2010

Sanli, Yasemin Et Al. "Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?." JOURNAL OF NUCLEAR MEDICINE , vol.51, 2010

Sanli, Y. Et Al. (2010) . "Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?." JOURNAL OF NUCLEAR MEDICINE , vol.51.

@article{article, author={Yasemin Sanli Et Al. }, title={Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?}, journal={JOURNAL OF NUCLEAR MEDICINE}, year=2010}